Decreasing prevalence of transmitted drug resistance among ART-naive HIV-1-infected patients in Iceland, 1996–2012
Introduction: Resistance to antiretroviral drugs can complicate the management of HIV-1 infection and impair control of its spread. The aim of the current study was to investigate the prevalence and transmission of HIV-1 drug resistance among 106 antiretroviral therapy (ART)-naïve patients diagnosed...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Infection Ecology & Epidemiology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20008686.2017.1328964 |
_version_ | 1819041879974477824 |
---|---|
author | Malik Sallam Gülşen Özkaya Şahin Hlynur Indriðason Joakim Esbjörnsson Arthur Löve Anders Widell Magnus Gottfreðsson Patrik Medstrand |
author_facet | Malik Sallam Gülşen Özkaya Şahin Hlynur Indriðason Joakim Esbjörnsson Arthur Löve Anders Widell Magnus Gottfreðsson Patrik Medstrand |
author_sort | Malik Sallam |
collection | DOAJ |
description | Introduction: Resistance to antiretroviral drugs can complicate the management of HIV-1 infection and impair control of its spread. The aim of the current study was to investigate the prevalence and transmission of HIV-1 drug resistance among 106 antiretroviral therapy (ART)-naïve patients diagnosed in Iceland (1996–2012). Methods: HIV-1 polymerase sequences were analysed using the Calibrated Population Resistance tool. Domestic spread of transmitted drug resistance (TDR) was investigated through maximum likelihood and Bayesian approaches. Results: Among ART-naïve patients, the prevalence of TDR to any of the following classes (NRTIs, NNRTIs and PIs) was 8.5% (95% CI: 4.5%- 15.4%): 6.6% to NRTIs, 0.9% to NNRTIs, and 1.9% to PIs. The most frequent NRTI mutation detected was T215C/D (n=7, 5.7%). The only NNRTI mutation detected was K103N (n=1, 0.9%). PI mutations detected were M46I (n=1, 0.9%) and L90M (n=1, 0.9%). Six patients harbouring T215C/D, were linked in a supported phylogenetic cluster. No significant association was found between TDR and demographic or risk groups. Trend analysis showed a decrease in the prevalence of TDR (1996–2012, p=0.003). Conclusions: TDR prevalence in Iceland was at a moderate level and decreased during 1996-2012. Screening for TDR is recommended to limit its local spread and to optimize HIV-1 therapy. A bbreviations: ART: Anti-retroviral therapy; ARV: antiretroviral; ATV/r: atazanavir/ritonavir; AZT: azidothymidine; BEAST: Bayesian evolutionary analysis by sampling trees; CI: confidence interval; CPR: calibrated population resistance; CRF: circulating recombinant form; d4T: stavudine; EFV: efavirenz; FET: Fishers’ exact test; FPV/r: fosamprenavir/ritonavir; HET: heterosexual; IDU: injection drug use; IDV/r: indinavir/ritonavir; LPV/r: lopinavir/ritonavir; MSM: men who have sex with men; M-W: Mann–Whitney U test; NFV: nelfinavir; NNRTIs: non-nucleoside reverse transcriptase inhibitors; NRTIs: nucleoside reverse transcriptase inhibitors; NVP: nevirapine; PIs: protease inhibitors; pol: polymerase gene; SDRM: surveillance drug resistance mutation; SQV/r: saquinavir/ritonavir; TDR: transmitted drug resistance |
first_indexed | 2024-12-21T09:32:01Z |
format | Article |
id | doaj.art-ea15b03057514f6ab18d644b8424b495 |
institution | Directory Open Access Journal |
issn | 2000-8686 |
language | English |
last_indexed | 2024-12-21T09:32:01Z |
publishDate | 2017-01-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Infection Ecology & Epidemiology |
spelling | doaj.art-ea15b03057514f6ab18d644b8424b4952022-12-21T19:08:44ZengTaylor & Francis GroupInfection Ecology & Epidemiology2000-86862017-01-017110.1080/20008686.2017.13289641328964Decreasing prevalence of transmitted drug resistance among ART-naive HIV-1-infected patients in Iceland, 1996–2012Malik Sallam0Gülşen Özkaya Şahin1Hlynur Indriðason2Joakim Esbjörnsson3Arthur Löve4Anders Widell5Magnus Gottfreðsson6Patrik Medstrand7Lund UniversityLaboratory Medicine SkåneUniversity of IcelandUniversity of OxfordUniversity of IcelandLund UniversityUniversity of IcelandLund UniversityIntroduction: Resistance to antiretroviral drugs can complicate the management of HIV-1 infection and impair control of its spread. The aim of the current study was to investigate the prevalence and transmission of HIV-1 drug resistance among 106 antiretroviral therapy (ART)-naïve patients diagnosed in Iceland (1996–2012). Methods: HIV-1 polymerase sequences were analysed using the Calibrated Population Resistance tool. Domestic spread of transmitted drug resistance (TDR) was investigated through maximum likelihood and Bayesian approaches. Results: Among ART-naïve patients, the prevalence of TDR to any of the following classes (NRTIs, NNRTIs and PIs) was 8.5% (95% CI: 4.5%- 15.4%): 6.6% to NRTIs, 0.9% to NNRTIs, and 1.9% to PIs. The most frequent NRTI mutation detected was T215C/D (n=7, 5.7%). The only NNRTI mutation detected was K103N (n=1, 0.9%). PI mutations detected were M46I (n=1, 0.9%) and L90M (n=1, 0.9%). Six patients harbouring T215C/D, were linked in a supported phylogenetic cluster. No significant association was found between TDR and demographic or risk groups. Trend analysis showed a decrease in the prevalence of TDR (1996–2012, p=0.003). Conclusions: TDR prevalence in Iceland was at a moderate level and decreased during 1996-2012. Screening for TDR is recommended to limit its local spread and to optimize HIV-1 therapy. A bbreviations: ART: Anti-retroviral therapy; ARV: antiretroviral; ATV/r: atazanavir/ritonavir; AZT: azidothymidine; BEAST: Bayesian evolutionary analysis by sampling trees; CI: confidence interval; CPR: calibrated population resistance; CRF: circulating recombinant form; d4T: stavudine; EFV: efavirenz; FET: Fishers’ exact test; FPV/r: fosamprenavir/ritonavir; HET: heterosexual; IDU: injection drug use; IDV/r: indinavir/ritonavir; LPV/r: lopinavir/ritonavir; MSM: men who have sex with men; M-W: Mann–Whitney U test; NFV: nelfinavir; NNRTIs: non-nucleoside reverse transcriptase inhibitors; NRTIs: nucleoside reverse transcriptase inhibitors; NVP: nevirapine; PIs: protease inhibitors; pol: polymerase gene; SDRM: surveillance drug resistance mutation; SQV/r: saquinavir/ritonavir; TDR: transmitted drug resistancehttp://dx.doi.org/10.1080/20008686.2017.1328964PhylogenyresistancetrendtransmissionBEAST |
spellingShingle | Malik Sallam Gülşen Özkaya Şahin Hlynur Indriðason Joakim Esbjörnsson Arthur Löve Anders Widell Magnus Gottfreðsson Patrik Medstrand Decreasing prevalence of transmitted drug resistance among ART-naive HIV-1-infected patients in Iceland, 1996–2012 Infection Ecology & Epidemiology Phylogeny resistance trend transmission BEAST |
title | Decreasing prevalence of transmitted drug resistance among ART-naive HIV-1-infected patients in Iceland, 1996–2012 |
title_full | Decreasing prevalence of transmitted drug resistance among ART-naive HIV-1-infected patients in Iceland, 1996–2012 |
title_fullStr | Decreasing prevalence of transmitted drug resistance among ART-naive HIV-1-infected patients in Iceland, 1996–2012 |
title_full_unstemmed | Decreasing prevalence of transmitted drug resistance among ART-naive HIV-1-infected patients in Iceland, 1996–2012 |
title_short | Decreasing prevalence of transmitted drug resistance among ART-naive HIV-1-infected patients in Iceland, 1996–2012 |
title_sort | decreasing prevalence of transmitted drug resistance among art naive hiv 1 infected patients in iceland 1996 2012 |
topic | Phylogeny resistance trend transmission BEAST |
url | http://dx.doi.org/10.1080/20008686.2017.1328964 |
work_keys_str_mv | AT maliksallam decreasingprevalenceoftransmitteddrugresistanceamongartnaivehiv1infectedpatientsiniceland19962012 AT gulsenozkayasahin decreasingprevalenceoftransmitteddrugresistanceamongartnaivehiv1infectedpatientsiniceland19962012 AT hlynurindriðason decreasingprevalenceoftransmitteddrugresistanceamongartnaivehiv1infectedpatientsiniceland19962012 AT joakimesbjornsson decreasingprevalenceoftransmitteddrugresistanceamongartnaivehiv1infectedpatientsiniceland19962012 AT arthurlove decreasingprevalenceoftransmitteddrugresistanceamongartnaivehiv1infectedpatientsiniceland19962012 AT anderswidell decreasingprevalenceoftransmitteddrugresistanceamongartnaivehiv1infectedpatientsiniceland19962012 AT magnusgottfreðsson decreasingprevalenceoftransmitteddrugresistanceamongartnaivehiv1infectedpatientsiniceland19962012 AT patrikmedstrand decreasingprevalenceoftransmitteddrugresistanceamongartnaivehiv1infectedpatientsiniceland19962012 |